V-5 Immunitor: Completed Phase IIb enrollment

Immunitor completed enrollment of 120 patients in the double-blind, placebo-controlled, Ukrainian Phase IIb Study

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE